American Medical Systems Announces Extension to July 19 of Cash Tender Offer for Laserscope Acquisition

American Medical Systems Holdings, Inc. (NASDAQ:AMMD),
the global leader in providing pelvic health solutions to urologists
and gynecologists, announced today that it has extended the expiration
date of its cash tender offer for shares of Laserscope (NASDAQ:LSCP).
   As previously announced and unanimously approved by the Boards of
Directors of both companies, the tender offer is to acquire all of the
outstanding shares of Laserscope at a purchase price of $31.00 net per
share, pursuant to an Agreement and Plan of Merger, dated June 3,
2006. The Laserscope Board of Directors has recommended that
Laserscope shareholders tender their shares into the offer. Through
the close of business on July 10, 2006, a total of 3,903,637
Laserscope shares had been tendered, constituting approximately 17.4
percent of the shares outstanding.
   The expiration for the tender offer has been extended to 12:00
midnight, central time, on Wednesday, July 19, 2006, unless further
extended. As initially announced, the tender offer was scheduled to
expire at 12:00 midnight, central time, on Wednesday, July 12, 2006.
Martin J. Emerson, President and Chief Executive Officer, commented,
"We have extended the tender offer period to allow for additional time
to reach our minimum condition of 90 percent of Laserscope shares
being tendered. In addition, while we have successfully completed our
offering of convertible senior subordinated notes, we have an
aggressive schedule to complete the senior secured loan facility to
fund a portion of the purchase price. We have completed the
syndication and negotiation of loan documentation for the senior
secured loan facility. The tender extension will allow completion of
the various procedural steps necessary to close the facility."

   About American Medical Systems

   American Medical Systems, headquartered in Minnetonka, Minnesota
is a diversified supplier of medical devices and procedures to cure
erectile dysfunction, benign prostatic hyperplasia, incontinence,
menorrhagia, prolapse and other pelvic disorders in men and women.
These disorders can significantly diminish one's quality of life and
profoundly affect social relationships. In recent years, the number of
people seeking treatment has increased markedly as a result of longer
lives, higher quality-of-life expectations and greater awareness of
new treatment alternatives. American Medical Systems' products reduce
or eliminate the incapacitating effects of these diseases, often
through minimally invasive therapies. The Company's products were used
to provide approximately 170,000 patient cures in 56 countries during
2005. More information about AMS can be found on its website at
www.AmericanMedicalSystems.com.

   About Laserscope

   Laserscope designs, manufactures, sells and services an advanced
line of minimally invasive medical products worldwide including
medical laser systems and related energy delivery devices for the
office, outpatient surgical center and hospital markets. More
information about Laserscope can be found on its website at
www.Laserscope.com.

   Additional Information

   This announcement is neither an offer to purchase nor a
solicitation of an offer to sell shares of Laserscope. American
Medical Systems Holdings, Inc. has filed a tender offer statement with
the Securities and Exchange Commission (SEC) and Laserscope has filed
a solicitation/recommendation statement with respect to the offer.
Laserscope shareholders are advised to read the tender offer statement
regarding the acquisition of Laserscope referenced in this news
release, and the related solicitation/recommendation statement. The
tender offer statement and the solicitation/recommendation statement
contain important information that should be read carefully before any
decision is made with respect to the offer. These documents will be
made available to all shareholders of Laserscope at no expense to
them. These documents will also be available at no charge on the SEC's
web site at www.sec.gov. Shareholders may also obtain copies of these
documents without charge by requesting them from Laserscope, Inc. in
writing at 3070 Orchard Drive, San Jose, CA 95134, or by phone at
408-943-0636.